Journal
JOURNAL OF MOLECULAR MODELING
Volume 16, Issue 4, Pages 799-804Publisher
SPRINGER
DOI: 10.1007/s00894-009-0627-6
Keywords
Diabetes mellitus; DFT; Drug design; Electronic properties; IEF-PCM
Categories
Funding
- FAPESP (The State of Sao Paulo Research Foundation)
- CNPq (The National Council for Scientific and Technological Development)
- CAPES (Coordination for the Improvement of High Education Personnel), Brazil
Ask authors/readers for more resources
Diabetes mellitus (DM) is a disease that affects a large number of people, and the number of problems associated with the disease has been increasing in the past few decades. These problems include cardiovascular disorders, blindness and the eventual need to amputate limbs. Therefore, the quality of life for people living with DM is less than it is for healthy people. In several cases, metabolic syndrome (MS), which can be considered a disturbance of the lipid metabolism, is associated with DM. In this work, two drugs used to treat DM, pioglitazone and rosiglitazone, were studied using theoretical methods, and their molecular properties were related to the biological activity of these drugs. From the results, it was possible to correlate the properties of each substance-particularly electronic properties-with the biological interactions that are linked to their pharmacological effects. These results suggest that there are future prospects for designing or developing new drugs based on the correlation between theoretical and experimental properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available